FDA proposes new system for approving customized drugs and therapies for rare diseases
The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare
Read MoreThe Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare
Read MoreThe pharma industry’s dreaded patent cliff is a key driver of the stock’s decline. Pharmaceutical companies spend a ton of
Read MoreSingapore, February 20, 2026 — AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60
Read MoreThe Richfield, Wisconsin manufacturing site is the 12th global facility for MGS. [Photo courtesy of MGS] MGS has brought a
Read MoreUPDATE: This post was updated at 11:49 a.m. with some remarks from Wednesday’s plant announcement. Another of the world’s top
Read MoreOnly 12 years ago, China’s biotech sector was filled with abundant enthusiasm but could not compete in the global drug-development
Read MoreWhen Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off
Read MoreEli Lilly isn’t a one-trick pony. It’s no secret that Eli Lilly‘s (LLY +0.33%) strong performance in recent years is
Read MoreEli Lilly continues to pursue smart acquisitions for the long term. The pharmaceutical industry can be a tricky investment. Remember
Read MoreFor decades, the pharmaceutical industry has relied on a predictable but increasingly sub-optimal operating model: leaders at global headquarters set
Read More